Emma Verheye,Daliya Kancheva,Hatice Satilmis,Niels Vandewalle,Rong Fan,Pauline M. R. Bardet,Emile J. Clappaert,Kevin Verstaen,Ann De Becker,Karin Vanderkerken,Kim De Veirman,Damya Laoui

Abstract:The long-term effectiveness of immunotherapies against Multiple Myeloma (MM) remains elusive, demonstrated by the inevitable relapse in patients. This underscores the urgent need for an in-depth analysis of the MM tumor-immune microenvironment (TME). Hereto, a representative immunocompetent MM mouse model can offer a valuable approach to study the dynamic changes within the MM-TME and to uncover potential resistance mechanisms hampering effective and durable therapeutic strategies in MM.

A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages